Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis

American Journal of Psychiatry

Volumn 166, Issue 2, 2009, Pages 236-

  Joffe, Grigori ^a   Eskelinen, Saana ^a   Sailas, Eila ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADD ON THERAPY; AGRANULOCYTOSIS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EPIGLOTTITIS; GRANULOCYTOPENIA; HUMAN; INFORMED CONSENT; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL; PSYCHOSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEPSIS; TONSILLITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FILGRASTIM; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; SCHIZOPHRENIA;

EID: 60349119290     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08081295     Document Type: Letter

References (2)

1. Majczenko T, Stewart J: Failure of filgrastim to prevent severe clozapine-induced agranulocytosis. South Med J 2008; 101:639-640
2. Hagg S, Rosenius S, Spigset O: Long-term combination treatment with clozapine and filgrastim in patients with clozapineinduced agranulocytosis. Int Clin Psychopharmacol 2003; 18:173-174